NCT06356168

Virtual Reality in End Stage Kidney Disease

Social Virtual Reality to Alleviate Loneliness and Symptoms for Individuals Receiving Hemodialysis

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 60 (estimated)
• Sponsor: University of Pennsylvania · Academic / Other
• Sex: All
• Age: —
• Healthy volunteers: Not accepted

Summary

The goal of this clinical trial to compare the social virtual reality and individual virtual reality in patients with end stage kidney disease who are hemodialysis. The main aim is to determine if there are differences in symptoms between the groups. Participants will use virtual reality glasses for 30-45 minutes during dialysis sessions for 4 weeks.

Detailed description

In a single site, 2-arm (Social Virtual Reality group; Individual Virtual Reality Group), parallel, randomized controlled trial we will enroll 60 subjects (n=30 per group) to assess the effects of Social Virtual Reality to Individual Virtual Reality on symptoms in participants with end stage kidney disease who are receiving hemodialysis. To compare the effects of social virtual reality to individual virtual reality on loneliness To explore the effects of social virtual reality to individual virtual reality on anxiety and depression. To compare the effects social virtual reality to individual virtual reality on quality of life.

Conditions

• End Stage Kidney Disease

Interventions

Type	Name	Description
BEHAVIORAL	Social Virtual Reality	Participants interact using virtual reality during dialysis.
BEHAVIORAL	Individual Virtual Reality	Participants use virtual reality alone during dialysis.

Timeline

• Start date: 2026-03-30
• Primary completion: 2026-05-31
• Completion: 2026-07-31
• First posted: 2024-04-10
• Last updated: 2026-04-06

Locations

1 site across 1 country: United States